Capillary Zone Electrophoresis for Recombinant HNS Charge Profiling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing recombinant heparan N-sulfatase (HNS) enzyme for treating Sanfilippo syndrome type A lack effective control over physiochemical properties, leading to variability in product quality and efficacy due to diverse glycoforms influenced by manufacturing processes.
Innovation Solution
The use of capillary zone electrophoresis to characterize the molecular charge of recombinant HNS, allowing for precise monitoring and standardization of charge heterogeneity, which impacts bio-efficacy, serum half-life, antigenicity, and solubility, thereby optimizing production processes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If recombinant HNS is produced using cell-based expression systems with diverse glycosylation sites, then the enzyme can achieve bio-efficacy through post-translational modifications, but the diversity of glycoforms creates variability in product quality, stability, and pharmacokinetic parameters
Solution Approach 1:
The patent applies parameter changes by using capillary zone electrophoresis to measure and control the charge parameter of recombinant HNS. By quantifying charge heterogeneity caused by glycosylation variations, the method enables monitoring and standardization of physiochemical properties across different batches, thereby resolving the contradiction between maintaining glycoform diversity for bio-efficacy and ensuring product quality consistency.
2Measurement precision
If traditional analytical methods are used to monitor recombinant HNS production, then the manufacturing process can proceed, but subtle physiochemical differences between batches cannot be detected, leading to quality variability
Solution Approach 1:
The patent replaces traditional mechanical/chromatographic analytical methods with capillary zone electrophoresis, which uses electrical fields to separate and detect charge variants of recombinant HNS. This substitution provides superior measurement precision for detecting subtle physiochemical differences while maintaining practical device complexity through the use of standardized capillary electrophoresis instrumentation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach ensures consistent and reliable production of recombinant HNS, enhancing its bio-efficacy and safety by standardizing charge profiles, leading to improved enzyme replacement therapy for Sanfilippo syndrome type A.
Implementation Method 1
the present invention is based on the discovery that capillary zone electrophoresis can be used to accurately characterize physiochemical properties of recombinant protein encoding an enzyme associated with a lysosomal storage disease
Implementation Method 2
capillary zone electrophoresis (CZE), are known. While each of these techniques offers strengths and weaknesses, the best method for resolving charge heterogeneity of a given protein is determined on a case-by-case basis
Data Source
AI summary
The present invention provides, among other things, methods for the characterization of recombinant Heparan N-Sulfatase (HNS) during manufacture. The present invention uses capillary zone electrophoresis to determine the charge profile, isoform distribution, and/or glycan profile of recombinant HNS; and represents a quality feature for the batch consistency, storage stability, biological half-life, pharmacokinetic, pharmacodynamic and biological activity of the enzyme. In particular, such characterization methods may be beneficial to optimize conditions and ensure consistency for the manufacture of HNS for the treatment of a patient diagnosed with Sanfilippo syndrome using enzyme replacement therapy.